CCS
Concentric Capital Strategies’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $420K | Buy |
+2,263
| New | +$420K | 0.02% | 233 |
|
2025
Q1 | – | Sell |
-1,357
| Closed | -$241K | – | 156 |
|
2024
Q4 | $241K | Sell |
1,357
-7,035
| -84% | -$1.25M | 0.01% | 232 |
|
2024
Q3 | $1.66M | Buy |
8,392
+2,753
| +49% | +$544K | 0.07% | 190 |
|
2024
Q2 | $967K | Buy |
+5,639
| New | +$967K | 0.05% | 223 |
|
2023
Q4 | – | Sell |
-3,423
| Closed | -$510K | – | 203 |
|
2023
Q3 | $510K | Buy |
+3,423
| New | +$510K | 0.05% | 151 |
|
2023
Q2 | – | Sell |
-11,838
| Closed | -$1.89M | – | 139 |
|
2023
Q1 | $1.89M | Buy |
+11,838
| New | +$1.89M | 0.62% | 63 |
|